Wire · regulatory
Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 5 August 2026 · Fusion42 review
Health Canada has authorized Moderna to start Phase 1 clinical trials of an mRNA vaccine targeting the Bundibugyo strain of the Ebola virus amid a severe outbreak in the Democratic Republic of the Congo. This vaccine uses mRNA technology from COVID-19 vaccines and could provide a critical tool for future Ebola outbreaks if successful.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it.
◆ ◆ The Wire takeaway
You face a new opening in infectious disease vaccine development as Health Canada fast-tracks mRNA trials for Ebola, creating a precedent for rapid response in neglected tropical diseases. This could accelerate market entry timelines and funding for health tech founders focused on epidemic control.
◆ Coverage
2 sources · 4 Aug 2026
◆ Related on Wire
◆ Topics